iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

USFDA inspects Gland Pharma's Dundigal Facility in Hyderabad

26 Aug 2022 , 09:19 AM

Gland Pharma Limited has informed to the exchanges regarding USFDA Inspection at Dundigal Facility, Hyderabad.
It is informed that the Office of Medical Device and Radiological Health Operations (OMDRHO), United States Food and Drug Administration (US FDA) conducted Pre-Market Inspection covering US FDA’s Quality System/Current Good Manufacturing Practice regulations for Medical Devices (21 CFR Part 820) at the Company’s Dundigal Facility at Hyderabad from August 22, 2022 to August 25, 2022.
Now, the Company has received 1 (ONE) observation on Form 483 with respect to ANDA filed for the product to be manufactured at the said Facility. There is no data integrity observation as for now, the company said.
It further added, the Company is committed to address the observation and will submit its response to US FDA within the stipulated time.

At around 9:19 AM, Gland Pharma was trading at Rs2396.05 per share lower by 0.29% on the BSE.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • Gland Pharma Limited
  • Gland Pharma Limited shares
  • Gland Pharma Limited stocks
  • news
  • USFDA inspection
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.